Similar to the genetic inhibition studies, HES1 pharmacologic inhibition by JI130 inhibited tumor xenograft growth over time (Fig. S8C,D), with lower average tumor weight after necropsy (Fig. S8E). Here, HES1 is linked to neoplasm.